Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;32(6):219-225.
doi: 10.1097/FPC.0000000000000477. Epub 2022 Jun 22.

Influence of CYP2B6 and CYP3A4 polymorphisms on the virologic and immunologic responses of patients treated with efavirenz-containing regimen

Affiliations

Influence of CYP2B6 and CYP3A4 polymorphisms on the virologic and immunologic responses of patients treated with efavirenz-containing regimen

Yaya Kassogue et al. Pharmacogenet Genomics. .

Abstract

Objectives: The main objective of this study was to evaluate the effect of CYP2B6 and CYP3A4 polymorphisms on the virological and immunologic responses of HIV patients. A total of 153 HIV-positive patients were enlisted for the study.

Patients and methods: Viral load and median CD4 T cell counts were evaluated at baseline and month 6 (M6). Samples were identified using TaqMan genotyping assays.

Results: The AG in CYP2B6 rs2279343 was associated with VLS compared to homozygous AA. In the dominant model, the AG/GG genotypes were associated with VLS compared to the AA genotype. Moreover, in overdominant model, the AG genotype was associated with VLS compared to AA/GG. Regarding immunological response, only the AG in SNP rs2279343 CYP2B6 was associated with an increase in CD4 cell count between baseline and M6. In CYP2B6 rs3745274, the CD4 cell count at M6 was higher than that of baseline for GG carriers and for GT carriers. In CYP3A4 rs2740574, the TC carriers showed a higher median CD4 count at M6 compared to that of the baseline count, as well as for CC carriers. The best genotypes combination associated with CD4 cell count improvement were AA/AG in SNP rs2279343 and GG/GT in SNP rs3745274.

Conclusion: Our findings support the fact that CYP2B6 rs2279343 could help in the prediction of VLS and both SNPs rs3745274 and rs2279343 in CYP2B6 and CYP3A4 rs2740574 were associated with immune recovery in Malian HIV-positive patients.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No conflict of interest

Figures

Figure 1
Figure 1
Median (interquartile range) evolution in CD4 T cell count from baseline to M6 in patients receiving efavirenz-containing therapy according to the different genotype profiles in the three SNPs. The light gray boxplot represents the baseline CD4 T cell count, while the dark gray boxplot represents the median CD4 T cell count at M6. The horizontal lines represent the median and the lower and upper limits of the boxplot represent 25% percentile and 75% percentile. Mann–Whitney test were used to compare CD4 T cell count from baseline to that of M6.
Figure 2
Figure 2
Median CD4 T cell count evolution from baseline to M6 in patients regarding the different combinations of wild-type homozygous/heterozygous in the three SNP. The light gray boxplot represents the baseline CD4 T cell count, while the dark gray boxplot represents the median CD4 T cell count at M6. The horizontal lines represent the median and the lower and upper limits of the boxplot represent 25% percentile and 75% percentile. Mann–Whitney test were used to compare CD4 T cell count from baseline to that of M6.

References

    1. UNAIDS. Jt United Nations Program HIV/AIDS Report. 2019 Retrieved from https//www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data .
    1. Bordin Andriguetti N, Van Schalkwyk HK, Barratt DT, Tucci J, Pumuye P, Somogyi AA. Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele. Clin Transl Sci. 2021;14:2521–31. - PMC - PubMed
    1. Rzeszutek M, Gruszczyńska E, Pięta MMP. HIV/AIDS stigma and psychological well-being after 40 years of HIV/AIDS: a systematic review and meta-analysis. Eur J Psychotraumatol. 2021;12(1):1990527. - PMC - PubMed
    1. Bengtson AM, Pence BW, Eaton EF, Edwards JK, Joseph J, Mathews WC, et al. Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999–2015. Antivir Ther. 2019;23:363–72. - PMC - PubMed
    1. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc. 2013;16:1–7. - PMC - PubMed

Publication types

MeSH terms